New York, NY – Key international stakeholders, diplomats and public health leaders will gather in New York City today to discuss ways to accelerate and collaborate on the global elimination of cervical cancer through vaccinations, screening, diagnostics and treatment.
You are here
WASHINGTON, D.C. – In partnership with the Centers for Disease Control and Prevention (CDC) through the Antimicrobial Resistance (AMR) Challenge, AdvaMedDx and several AdvaMedDx member companies made public commitments to bolster efforts to combat the global prevalence of AMR. The CDC will be accepting commitments over the course of the next year.
Washington, D.C. – AdvaMedDx applauds Capitol Hill's release of technical assistance (TA) developed by the Food and Drug Administration (FDA) to draft legislation authored by Representatives Larry Bucshon (R-IN) and Diana DeGette (D-CO) as a significant, positive step toward enacting legislation modernizing regulation of all diagnostics, including Laboratory Developed Tests (LDTs).